PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

The Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace, NOT-MH-21-125, encourages the translation of BRAIN Initiative-supported technologies from academic and other non-small business research sectors to the marketplace. Small Business Concerns (SBCs) are encouraged to submit Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications that propose to further develop, optimize, validate and scale such technologies for commercial dissemination. Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date (January 6, 2024) of NOT-MH-21-125: PA-21-259 (SBIR Omnibus/Parent Clinical Trial Not Allowed) and PA-21-262 (STTR Omnibus/Parent Clinical Trial Not Allowed). 

PA-21-259
Thursday, July 8, 2021
Wednesday, April 6, 2022
Closed
Program: